FEATURES OF ATOPIC DERMATITIS IN CHILDREN
Keywords:
pruritic dermatitis, eczema, allergy, Netherton syndrome, hyper-IgE syndromeAbstract
Atopic dermatitis (AD) is a relapsing, chronic, non-infectious, inflammatory skin disease characterized by persistent pruritus, with an incidence of up to 20% in children. In recent decades, the incidence of AD in children has been increasing every year in both developed and developing countries. The clinical manifestations of AD in children include eczema-like rashes such as erythema, papules, and exudative lesions at specific sites. As a non-fatal skin disease, AD in children imposes a significant psychosocial burden on patients and their families. The main comorbidities associated with AD are infections, including Staphylococcus aureus superinfection and eczema herpeticum; however, chronic pruritus and loss of sleep, as well as the time and expense associated with treatment, are often the most distressing for patients and their families.
References
Böttcher MF, Abrahamsson TR, Fredriksson M, et al. Low breast milk TGF-beta2 is induced by Lactobacillus reuteri supplementation and associates with reduced risk of sensitization during infancy. Pediatr Allergy Immunol 2018;19:497-504.
Boyle RJ, Ismail IH, Kivivuori S, et al. Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial. Allergy 2021;66:509-16.
Cabana MD, McKean M, Caughey AB, et al. Early Probiotic Supplementation for Eczema and Asthma Prevention: A Randomized Controlled Trial. Pediatrics 2017;140:e20163000.
Compare D, Sgamato C, Nardone OM, et al. Probiotics in Gastrointestinal Diseases: All that Glitters Is Not Gold. Dig Dis 2022;40:123-32.
Dinan TG, Cryan JF. The Microbiome-Gut-Brain Axis in Health and Disease. Gastroenterol Clin North Am 2017;46:77-89.
Fleischer DM, Bock SA, Spears GC, Wilson CG, Miyazawa NK, Gleason MC и др. Оральные пищевые провокации у детей с диагнозом пищевая аллергия. Журнал педиатрии. Апрель 2019 г.;158(4):578–83. e1. doi: 10.1016/j.jpeds.2010.09.027. PubMed PMID: 21030035.
Gibson GR, Hutkins R, Sanders ME, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol 2017;14:491-502.
Giron M, Thomas M, Dardevet D, et al. Gut microbes and muscle function: can probiotics make our muscles stronger? J Cachexia Sarcopenia Muscle 2022;13:1460-76.
Guimarães P, Batista A, Zieger M, et al. Artificial Intelligence in Multiphoton Tomography: Atopic Dermatitis Diagnosis. Sci Rep 2020;10:7968.
Håkansson Å, Andrén Aronsson C, Brundin C, et al. Effects of Lactobacillus plantarum and Lactobacillus paracasei on the Peripheral Immune Response in Children with Celiac Disease Autoimmunity: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Nutrients 2019;11:1925.
Han C. Early application of probiotics in the prevention of neonatal eczema [Master]. Beijing: North China University of Science and Technology, 2019.
Johnson H, Yu J. Current and Emerging Therapies in Pediatric Atopic Dermatitis. Dermatol Ther (Heidelb) 2022;12:2691-703. [Crossref] [PubMed]
Khoder G, Al-Yassir F, Al Menhali A, et al. Probiotics Upregulate Trefoil Factors and Downregulate Pepsinogen in the Mouse Stomach. Int J Mol Sci 2019;20:3901
Lockhart MK, Siegfried EC. Evolving Landscape of Systemic Therapy for Pediatric Atopic Dermatitis. Dermatol Clin 2022;40:137-43.
Lynch SV, Pedersen O. The Human Intestinal Microbiome in Health and Disease. N Engl J Med 2016;375:2369-79.
Mubanga M, Lundholm C, D'Onofrio BM, et al. Association of Early Life Exposure to Antibiotics With Risk of Atopic Dermatitis in Sweden. JAMA Netw Open 2021;4:e215245.
Naik PP. Recent insights into the management of treatment-resistant pediatric atopic dermatitis. Int J Womens Dermatol 2022;8:e023.
Pan H, Su J. Association of Probiotics with Atopic Dermatitis among Infant: A Meta-analysis of Randomized Controlled Trials. Oxid Med Cell Longev 2022;2022:5080190.
Peldan P, Kukkonen AK, Savilahti E, et al. Perinatal probiotics decreased eczema up to 10 years of age, but at 5-10 years, allergic rhino-conjunctivitis was increased. Clin Exp Allergy 2017;47:975-9.
Rø ADB, Simpson MR, Rø TB, et al. Reduced Th22 cell proportion and prevention of atopic dermatitis in infants following maternal probiotic supplementation. Clin Exp Allergy 2017;47:1014-21.
Schmidt RM, Pilmann Laursen R, Bruun S, et al. Probiotics in late infancy reduce the incidence of eczema: A randomized controlled trial. Pediatr Allergy Immunol 2019;30:335-40.
Shen X, Wang M, Zhang X, et al. Dynamic construction of gut microbiota may influence allergic diseases of infants in Southwest China. BMC Microbiol 2019;19:123.
Simpson MR, Dotterud CK, Storrø O, et al. Perinatal probiotic supplementation in the prevention of allergy related disease: 6 year follow up of a randomised controlled trial. BMC Dermatol 2015;15:13.
Snigdha S, Ha K, Tsai P, et al. Probiotics: Potential novel therapeutics for microbiota-gut-brain axis dysfunction across gender and lifespan. Pharmacol Ther 2022;231:107978. [Crossref] [PubMed]
Sun S, Chang G, Zhang L. The prevention effect of probiotics against eczema in children: an update systematic review and meta-analysis. J Dermatolog Treat 2022;33:1844-54.
Tokura Y, Hayano S. Subtypes of atopic dermatitis: From phenotype to endotype. Allergol Int 2022;71:14-24. [Crossref] [PubMed]
Voigt J, Lele M. Lactobacillus rhamnosus Used in the Perinatal Period for the Prevention of Atopic Dermatitis in Infants: A Systematic Review and Meta-Analysis of Randomized Trials. Am J Clin Dermatol 2022;23:801-11.
Wickens K, Barthow C, Mitchell EA, et al. Effects of Lactobacillus rhamnosus HN001 in early life on the cumulative prevalence of allergic disease to 11 years. Pediatr Allergy Immunol 2018;29:808-14.
Wickens K, Barthow C, Mitchell EA, et al. Maternal supplementation alone with Lactobacillus rhamnosus HN001 during pregnancy and breastfeeding does not reduce infant eczema. Pediatr Allergy Immunol 2018;29:296-302.
Wickens K, Black P, Stanley TV, et al. A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years. Clin Exp Allergy 2012;42:1071-9.
Williams H, Robertson C, Stewart A, Ait-Khaled N, Anabwani G, Anderson R и др. Мировые вариации распространенности симптомов атопической экземы в Международном исследовании астмы и аллергии у детей. Журнал аллергии и клинической иммунологии. 2019 Январь;103(1 Pt 1):125–38. doi: 10.1016/s0091-6749(99)70536-1. PubMed PMID: 9893196.
Yadav MK, Kumari I, Singh B, et al. Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics. Appl Microbiol Biotechnol 2022;106:505-21.
Zhou Q, Chen ZH, Zhang JX, et al. A systematic review of the quality of reporting and risk of bias for randomized crossover trials in digestive disease journals. Therap Adv Gastroenterol 2022;15:17562848211067874.
Закирова Б. И. и др. Бронхообструктивный синдром: прогностическая значимость дисбиоза кишечника в его развитии //Достижения науки и образования. – 2020. – №. 10 (64). – С. 83-85.
Хамраев Х. Т. и др. Особенности течения и осложнений муковисцидоза в зависимости от возраста //Наука, образование и культура. – 2020. – №. 6 (50). – С. 76-78.
Шавази Н. и др. Совершенствование лечения пневмонии с атипичной этиологией у детей //Журнал вестник врача. – 2021. – Т. 1. – №. 2. – С. 109-112.
Шавази Н. М. и др. Значимость факторов риска лекарственных отравлений у детей //Достижения науки и образования. – 2020. – №. 9 (63). – С. 80-82.
Шавази Н. М. и др. Современные взгляды возникновения обструктивной болезни легких у детей //Journal of cardiorespiratory research. – 2021. – Т. 2. – №. 1. – С. 40-43.
